LinusBio

North Brunswick, NJ · Founded 2020 · Privately Held (backing)

Developer of a precision exposome medicine platform designed to analyze the molecular impact of environmental exposures on health. LinusBio is based in North Brunswick, NJ and was founded in 2020. Its last reported valuation was $171 million in Jul 2024. It has raised $34.6 million.

Last reported valuation

$171.2M

Oct 2026

Priced at

—

Total raised

$34.6M

Last round

—

How much has LinusBio raised?

$34.6Macross 0 recorded rounds

Free account

More of LinusBio with a free account

·Watch LinusBio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

LinusBio investors

9 investors are on record for LinusBio, including GreatPoint Ventures, Bow Capital, Crom Capital Management and David Bellet Family Office.

For fundraisers

Raising for a company like LinusBio?

9 investors have backed LinusBio.

See all 9 investors →

Frequently asked about LinusBio

How much has LinusBio raised?: LinusBio has raised $34.6M in total across 0 recorded funding rounds.